Q4 2024 Earnings Call Transcript February 10, 2025 Inspire Medical Systems, Inc. beats earnings expectations. Reported EPS is ...

Inspire Medical Systems, Inc. ( NYSE: INSP) Q4 2024 Earnings Conference Call February 10, 2025 5:00 PM ET Ezgi Yagci - Vice President of Investor Relations Tim Herbert - President & Chief Executive ...

CEO Tim Herbert highlighted milestones in 2024, including surpassing 90,000 patients treated with Inspire therapy, FDA approval of the Inspire V neurostimulator, and achieving full-body MRI ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Inspire Medical Systems (INSP – Research ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Zoetis (ZTS – Research Report), Inspire Medical Systems ...

CEO Tim Herbert told investors the company received a civil investigative demand from the Department of Justice in January ...

Inspire Medical shares dipped — but have since mostly recovered — following news of a government investigation following Q4 ...

Inspire Medical Systems ( INSP -0.64%), known for its innovative devices that use neurostimulation to treat sleep apnea, ...

Inspire Medical Systems Inc (NYSE:INSP) is set to release its Q4 2024 earnings on Feb 10, 2025. The consensus estimate for Q4 2024 revenue is $0.24 billion, and the earnings are expected to come in at ...

Medical technology company Inspire Medical Systems (NYSE:INSP) reported Q4 CY2024 results , with sales up 24.5% year on year ...